Skip to content

Dudrick Research Symposium

Jan 24 | 8:00AM - 10:00AM

Novel Therapeutic Strategies for Critical Care (Small Peptides) (W10)

Novel Therapeutic Strategies for Critical Care (Small Peptides) (W10)

The 2017 Dudrick Award winner, Sadeq A. Quraishi, MD, MHA, MMSc, has the honor of planning the 2018 SadeqASPEN Nutrition Science and Practice Conference Dudrick Research Symposium. Dr. Quraishi is Associate Director for Clinical Research and Assistant Anesthetist in the Department of Anesthesia, Critical Care and Pain Medicine at Massachusetts General Hospital in Boston, MA. He is also Assistant Professor of Anesthesia at Harvard Medical School in Boston, MA. Dr. Quraishi started his career with a degree in Physical Therapy (BScPT) from McGill University and practiced as a staff therapist at Penn State's Milton S. Hershey Medical Center. He then went on to receive his Masters in Health Administration (MHA) and his Medical Doctorate (MD) from the Pennsylvania State University’s School of Public Affairs and College of Medicine, respectively. He also completed post-graduate training in Anesthesiology at Penn State’s Milton S. Hershey Medical Center, received further training in Intensive Care Medicine at the Johns Hopkins University School of Medicine, and completed advanced research training (MMSc) at Harvard Medical School and the Harvard School of Public Health. 

Dr. Quraishi’s research focuses on identifying risk factors for suboptimal perioperative outcomes and on promoting cost-effective solutions to improve the care of surgical patients.  Dr. Quraishi’s overall research goal is to improve human health using evidence-based nutritional strategies including defining how macro- and micro-nutrient status influence outcomes during acute stress and critical illness in hospitalized patients. His research group has focused on the effects of vitamin D on innate immune responses during critical illness and novel initiatives regarding the preservation or improvement of lean body mass in surgical patients. Recently, Dr. Quraishi’s group has identified vitamin D status as a potentially modifiable risk factor for hospital acquired C. diff infections and that the severity of C. Diff infections may also be related to vitamin D status. Other areas of research that Dr. Quraishi is involved with include novel strategies to maintain lean body mass and the design of innovative feeding protocols to minimize caloric/protein debt in hospitalized patients.

Recognized by his colleagues in the field, Dr. Quraishi strongly engages in the mentorship of young physicians, pharmacists, nurses, and dieticians in the area of clinical research in hopes of inspiring junior researchers and spreading the value of multidisciplinary research teams. Working towards executive leadership, Dr. Quraishi hopes to build a strong agenda centered on improving the scientific rigor of nutrition research and foster more meaningful opportunities for research.

Dr. Quraishi is sure to plan an invigorating symposium that you will not want to miss!


  1. Summarize the most up-to-date data on key metabolic processes involved in sepsis, with a focus on lean body mass preservation
  2. Discuss the potential role of beta-hydroxy-beta-methylbutyrate (HMB) and ghrelins in preservation of lean body mass
  3. Identify ways to promote anabolic responses in the critically ill patient


Key Metabolic Processes Involved in Sepsis
Paul Wischmeyer, MD, EDIC

Role of Beta-Hydroxy-Beta-Methylbutyrate (HMB) and Ghrelins in Preservation of Lean Body Mass and Promotion of Anabolic Responses in the Critically Ill Patient
Nicolaas Duetz, MD, PhD

Role of Beta-Hydroxy-Beta-Methylbutyrate (HMB) and Ghrelins in Preservation of Lean Body Mass and Promotion of Anabolic Responses in the Critically Ill Patient
M. Scott Harris, MD, MS, FACP, AGAF


Sadeq Quraishi, MD, MHA, MMSc

UAN: J0002345-0000-18-025-L04-P
CE CREDIT: 2 hours